Citation

BibTex format

@article{Greenhawt:2023:10.1016/j.jaci.2023.05.019,
author = {Greenhawt, M and Dribin, TE and Abrams, EM and Shaker, M and Chu, DK and Golden, DB and Akin, C and Anagnostou, A and ALMuhizi, F and Alqurashi, W and Arkwright, P and Baldwin, JL and Banerji, A and Bégin, P and Ben-Shoshan, M and Bernstein, J and Bingeman, TA and Bindslev-Jensen, C and Blumenthal, K and Byrne, A and Cahil, J and Cameron, S and Campbell, D and Campbell, R and Cavender, M and Chan, ES and Chinthrajah, S and Comberiatti, P and Eastman, JJ and Ellis, AK and Fleischer, DM and Fox, A and Frischmeyer-Guerrerio, PA and Gagnon, R and Garvey, LH and Grayson, MH and Clarisse, Isabwe GA and Hartog, N and Hendron, D and Horner, CC and O'B, Hourihane J and Iglesia, E and Kan, M and Kaplan, B and Katelaris, CH and Kim, H and Kelso, JM and Kahn, DA and Lang, D and Ledford, D and Levin, M and Lieberman, JA and Loh, R and Mack, DP and Mazer, B and Mody, K and Mosnaim, G and Munblit, D and Mustafa, SS and Nanda, A and Nathan, R and Oppenheimer, J and Otani, IM and Park, M and Pawankar, },
doi = {10.1016/j.jaci.2023.05.019},
journal = {Journal of Allergy and Clinical Immunology},
pages = {309--325},
title = {Updated guidance regarding the risk ofAllergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach.},
url = {http://dx.doi.org/10.1016/j.jaci.2023.05.019},
volume = {152},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - This guidance updates 2021 GRADE recomendations regarding immediate allergic reactions following COVID-19 vaccines and addresses re-vaccinating individuals with 1st dose allergic reactions and allergy testing to determine re-vaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 re-vaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions. GRADE methods informed rating the certainty of evidence and strength of recommenations. A modified Delphi panel consisting of experts in allergy, anaphylaxis, vaccinology, infectious diseases, emergency medicine, and primary care from Australia, Canada, Europe, Japan, South Africa, the UK, and the US formed the recommendations. We recommend vaccination for persons without COVID-19 vaccine excipient allergy, and re-vaccination after a prior immediate allergic reaction. We suggest against >15-minute post-vaccination observation. We recommend against mRNA vaccine or excipient skin testing to predict outcomes. We suggest re-vaccination of persons with an immediate allergic reaction to the mRNA vaccine or excipients be performed by a person with vaccine allergy expertise, in a properly equipped setting. We suggest against pre-medication, split-dosing, or special precautions because of a comorbid allergic history.
AU  - Greenhawt,M
AU  - Dribin,TE
AU  - Abrams,EM
AU  - Shaker,M
AU  - Chu,DK
AU  - Golden,DB
AU  - Akin,C
AU  - Anagnostou,A
AU  - ALMuhizi,F
AU  - Alqurashi,W
AU  - Arkwright,P
AU  - Baldwin,JL
AU  - Banerji,A
AU  - Bégin,P
AU  - Ben-Shoshan,M
AU  - Bernstein,J
AU  - Bingeman,TA
AU  - Bindslev-Jensen,C
AU  - Blumenthal,K
AU  - Byrne,A
AU  - Cahil,J
AU  - Cameron,S
AU  - Campbell,D
AU  - Campbell,R
AU  - Cavender,M
AU  - Chan,ES
AU  - Chinthrajah,S
AU  - Comberiatti,P
AU  - Eastman,JJ
AU  - Ellis,AK
AU  - Fleischer,DM
AU  - Fox,A
AU  - Frischmeyer-Guerrerio,PA
AU  - Gagnon,R
AU  - Garvey,LH
AU  - Grayson,MH
AU  - Clarisse,Isabwe GA
AU  - Hartog,N
AU  - Hendron,D
AU  - Horner,CC
AU  - O'B,Hourihane J
AU  - Iglesia,E
AU  - Kan,M
AU  - Kaplan,B
AU  - Katelaris,CH
AU  - Kim,H
AU  - Kelso,JM
AU  - Kahn,DA
AU  - Lang,D
AU  - Ledford,D
AU  - Levin,M
AU  - Lieberman,JA
AU  - Loh,R
AU  - Mack,DP
AU  - Mazer,B
AU  - Mody,K
AU  - Mosnaim,G
AU  - Munblit,D
AU  - Mustafa,SS
AU  - Nanda,A
AU  - Nathan,R
AU  - Oppenheimer,J
AU  - Otani,IM
AU  - Park,M
AU  - Pawankar,R
AU  - Perrett,KP
AU  - Peter,J
AU  - Phillips,EJ
AU  - Picard,M
AU  - Pitlick,M
AU  - Ramsey,A
AU  - Rasmussen,TH
AU  - Rathkopf,MM
AU  - Reddy,H
AU  - Robertson,K
AU  - Rodriguez,Del Rio P
AU  - Sample,S
AU  - Sheshradi,A
AU  - Shiek,J
AU  - Sindher,SB
AU  - Spergel,JM
AU  - Stone,CA
AU  - Stukus,D
AU  - Tang,ML
AU  - Tracy,JM
AU  - Turner,PJ
AU  - Vander,Leek TK
AU  - Wallace,DV
AU  - Wang,J
AU  - Wasserman,S
AU  - Weldon,D
AU  - Wolfson,AR
AU  - Worm,M
AU  - Yacoub,M-R
DO  - 10.1016/j.jaci.2023.05.019
EP  - 325
PY  - 2023///
SN  - 0091-6749
SP  - 309
TI  - Updated guidance regarding the risk ofAllergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach.
T2  - Journal of Allergy and Clinical Immunology
UR  - http://dx.doi.org/10.1016/j.jaci.2023.05.019
UR  - https://www.ncbi.nlm.nih.gov/pubmed/37295474
UR  - https://www.sciencedirect.com/science/article/pii/S0091674923007467?via%3Dihub
VL  - 152
ER  -
Download